Trials / Conditions / Palmoplantar Psoriasis
Palmoplantar Psoriasis
6 registered clinical trials studyying Palmoplantar Psoriasis — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real) NCT06802848 | Chongqing Genrix Biopharmaceutical Co., Ltd | — |
| Terminated | A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar NCT06042920 | Bristol-Myers Squibb | Phase 4 |
| Unknown | Brodalumab in Palmoplantar Psoriasis NCT04622033 | First OC Dermatology | Phase 4 |
| Completed | Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis NCT04720105 | Icahn School of Medicine at Mount Sinai | Phase 4 |
| Completed | Efficacy Study of TEPSO® Socks in Improving Palmoplantar Psoriasis NCT01197976 | Lenzi Egisto S.P.A. | Phase 2 |
| Completed | Safety and Efficacy of Infliximab in Palmoplantar Psoriasis NCT00629772 | Innovaderm Research Inc. | Phase 3 |